This interesting role in breast cancer may be due to the inhibition of TGF-β with subsequent activation of programmed cell death 4 (PDCD4), decrease of MMP-3 and MMP-9 and increase of cell adhesion [64]. This evidence concerns the gene MMP9 and breast carcinoma.